Powering the discovery and development of advanced therapeutics with our genome engineering platforms and induced pluripotent stem cell (iPSC) technology.
New Year, same us. Well—mostly.
Join us on our journey as we reach for 96% success rates, striving to invert the drug failure paradigm.
Check out how we're leading the charge through biological relevance, engineered precision, and GMP expertise:
hubs.ly/Q034PFsg0
Interested in working with induced pluripotent stem cell technology? We can help with that!
Meet with Cassandra at @LSEvendorshows to learn how we can advance your science with our proven iPSC generation & iPSC gene editing services. #iPSCs#StemCells#Antibodies#CellTherapy
[Upcoming Event]
Join us at Neuroscience 2023. We invite you to visit our booth (#510) November 11-15 to learn about our gene editing platform and new cell manufacturing capabilities.
🔗 appliedstemcell.com/upcoming…
[Stay On Target With ceBE-X]
Base edit with confidence! Use ASC's new ceBE-X gene editing technology for knockout and point mutation cell line model generation. Avoid off-target events and common licensing fees with ceBE-X! ✨
🔗appliedstemcell.com/research…#geneediting
[Explore & Discover ~ iPSC-DERIVED CELLS 🔬]
August is here and ASC's summer ☀️ iPSC sale is in full swing!
🔗 appliedstemcell.com/summer-c…
What iPSC-derived cells are you working with this summer?
[Explore & Discover ~ iPSC-DERIVED CELLS 🔬]
What iPSC-derived cell line do you need for your research? Explore ASC's iPSC-derived cell product catalog and discover the cell line that can help transform your research.
🔗appliedstemcell.com/products…#ipsc#cellandgenetherapy
Applied StemCell Inc. partners with CIRM to provide clinical-grade iPSCs and access to its proprietary gene editing technologies to accelerate the development of regenerative therapies.
appliedstemcell.com/applied-…
Meet our team at the booth #327 at the ISSCR. As a leading gene and cell therapy CRO/CDMO, we seek to support gene-editing and stem cell innovation for biomedical research and product development.
Join our team of experts at the 2023 ASGCT Annual Meeting. As a leading gene and cell therapy CRO/CDMO, we seek to support gene-editing and stem cell innovation for biomedical research and product development.